Cell-permeable peptide inhibitors of the JNK signal...

Details Cell-permeable peptide inhibitors of the JNK signal... Cell-permeable peptide inhibitors of the JNK signal...

2005-09-12

2011-12-20

Steadman, David J (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S018900, C514S021300

Reexamination Certificate

active

08080517

ABSTRACT:
The present invention refers to protein kinase inhibitors and more specifically to inhibitors of the protein kinase c-Jun amino terminal kinase. Additionally, the present invention provides JNK inhibitor sequences, chimeric peptides, nucleic acids encoding same as well as pharmaceutical compositions for treating pathophysiologies associated with JNK signaling.

REFERENCES:
patent: 4631211 (1986-12-01), Houghten
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: 4732890 (1988-03-01), Bonelli et al.
patent: 5597895 (1997-01-01), Gaynor et al.
patent: 5670617 (1997-09-01), Frankel et al.
patent: 5672479 (1997-09-01), Johnson et al.
patent: 5674980 (1997-10-01), Frankel et al.
patent: 5686264 (1997-11-01), Gaynor et al.
patent: 5747641 (1998-05-01), Frankel et al.
patent: 5756684 (1998-05-01), Johnson et al.
patent: 5804604 (1998-09-01), Frankel et al.
patent: 5840313 (1998-11-01), Vahlne et al.
patent: 5880261 (1999-03-01), Waeber et al.
patent: 5989814 (1999-11-01), Frankel et al.
patent: 5994108 (1999-11-01), Gaynor et al.
patent: 5994109 (1999-11-01), Woo et al.
patent: 6043083 (2000-03-01), Davis
patent: 6117632 (2000-09-01), O'Mahony
patent: 6284456 (2001-09-01), Jones et al.
patent: 6300317 (2001-10-01), Szoka, Jr. et al.
patent: 6316003 (2001-11-01), Frankel et al.
patent: 6348185 (2002-02-01), Piwnica-Worms
patent: 6448283 (2002-09-01), Ylikoski et al.
patent: 6495663 (2002-12-01), Rothbard et al.
patent: 6586403 (2003-07-01), Mathison et al.
patent: 6610820 (2003-08-01), Bonny
patent: 6630351 (2003-10-01), Monahan et al.
patent: 6653443 (2003-11-01), Zhang et al.
patent: 6740524 (2004-05-01), Akuta et al.
patent: 6780970 (2004-08-01), Bonny
patent: 6881825 (2005-04-01), Robbins et al.
patent: 6960648 (2005-11-01), Bonny
patent: 7034109 (2006-04-01), Bonny
patent: 2002/0103229 (2002-08-01), Bhagwat et al.
patent: 2003/0100549 (2003-05-01), Salituro et al.
patent: 2003/0104622 (2003-06-01), Robbins et al.
patent: 2003/0108539 (2003-06-01), Bonny
patent: 2003/0124113 (2003-07-01), Hillman et al.
patent: 2003/0220480 (2003-11-01), Bonny
patent: 2004/0082509 (2004-04-01), Bonny
patent: 2004/0265879 (2004-12-01), Iversen et al.
patent: 2005/0059597 (2005-03-01), Tymianski
patent: 2005/0106695 (2005-05-01), Bonny
patent: 2006/0223807 (2006-10-01), Davis et al.
patent: 2006/0258706 (2006-11-01), Saindane et al.
patent: 2006/0270646 (2006-11-01), Graczyk et al.
patent: 2007/0003531 (2007-01-01), Mukherji et al.
patent: 2008/0008749 (2008-01-01), Pearlman et al.
patent: 0679716 (1995-11-01), None
patent: 0897002 (1999-02-01), None
patent: 1364949 (2003-11-01), None
patent: 58-146538 (1983-09-01), None
patent: 02-221294 (1990-04-01), None
patent: 93/18759 (1993-09-01), None
patent: 94/04562 (1994-03-01), None
patent: 94/05311 (1994-03-01), None
patent: WO 94/04686 (1994-03-01), None
patent: 94/23751 (1994-10-01), None
patent: WO 95/34295 (1995-12-01), None
patent: WO 97/05265 (1997-02-01), None
patent: WO 97/10836 (1997-03-01), None
patent: WO 98/11907 (1998-03-01), None
patent: 98/23781 (1998-06-01), None
patent: WO 98/44106 (1998-10-01), None
patent: WO 98/47913 (1998-10-01), None
patent: 98/49188 (1998-11-01), None
patent: 98/51325 (1998-11-01), None
patent: 98/51825 (1998-11-01), None
patent: WO 98/52614 (1998-11-01), None
patent: 99/07728 (1999-02-01), None
patent: 99/16787 (1999-04-01), None
patent: 99/50282 (1999-10-01), None
patent: WO 99/49879 (1999-10-01), None
patent: 99/58561 (1999-11-01), None
patent: 99/67284 (1999-12-01), None
patent: 00/12587 (2000-03-01), None
patent: 01/10888 (2001-02-01), None
patent: 01/13957 (2001-03-01), None
patent: 01/15511 (2001-03-01), None
patent: WO 01/27268 (2001-04-01), None
patent: 02/31109 (2002-04-01), None
patent: 02/061105 (2002-08-01), None
patent: 02/062396 (2002-08-01), None
patent: 02/065986 (2002-08-01), None
patent: 02/069930 (2002-09-01), None
patent: 02/081505 (2002-10-01), None
patent: WO 02/081504 (2002-10-01), None
patent: 03/075917 (2003-09-01), None
patent: 03/103698 (2003-12-01), None
patent: 03/103718 (2003-12-01), None
patent: 2004/022580 (2004-03-01), None
patent: 2004/035793 (2004-04-01), None
patent: 2004/045535 (2004-06-01), None
patent: 2004/054501 (2004-07-01), None
patent: 2004/070052 (2004-08-01), None
patent: 2004/092339 (2004-10-01), None
patent: 2005/084158 (2005-09-01), None
patent: 2005/097116 (2005-10-01), None
patent: 2007/031098 (2007-03-01), None
patent: 2008/028860 (2008-03-01), None
patent: 2009/143864 (2009-12-01), None
patent: 2009/143865 (2009-12-01), None
Branden et al., “Introduction to Protein Structure”, Garland Publishing Inc., New York, 1991, p. 247.
Bonny et al., Diabetes 50:77-82, 2001.
Abaza et al. “Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization; demonstration with region 94-100 (antigenic site 3) of myoglobin” J. Protein Chem. 11(5), pp. 433-444 (1992).
Adle-Biassette et al. “Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage” Neuropathol. Appl. Neurobiol., 25(2);123-133 (1999).
Agrawal et al. “Promiscuous binding nature of SH3 domains to their target proteins”, Protein Pept. Lett., 9(3):185-193 (2002).
Barr et al. “Identification of the critical features of a small peptide inhibitor ofJNK activity”, J. Biol. Chem. 277(13), pp. 10987-10997 (2002).
Bonny et al. “IB1, a JIP-I-related nuclear protein present in insulin-secreting cells”, J. Biol. Chem., 273(4):1843-1846 (1998).
Bonny et al. “Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases”, Rev. Neurosei. 16(1), pp. 57-67 (2005).
Borsello et al. “A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia”, Nat Med. 9(9), pp. 1180-1186 (2003).
Borsello et al. “Use of cell-permeable peptides to prevent neuronal degeneration” Trends Mol. Med. 10(5), pp. 239-244 (2004).
Creighton, T. Encyclopedia of Molecular Biology, John Wiley and Sons, Inc. New York, pp. 2027-2033 (1999).
D. Wilson. Preventing Nerve Cell Death in ALS. Internet document <http://www.als.ca/—news/57.aspx˜2 pages, Dec. 5, 2001, accessed Aug. 23, 2006.
Database Uniprot Feb. 28, 2003, XP002366175, Retrieved from EBI, Database accession No. Q9WVI9 abstract.
Dickens et al. “A cytoplasmic inhibitor of the JNK signal transduction pathway”, Science, 277(5326):693-696 (1997).
EMBL Database Entry, GenBank accession No. AAD20443 (1999).
EMBL Database Entry, GenBank accession No. AAF 32323 (2000).
EMBL Database Entry. GenBank accession No. AF074091 (1999).
EMBL Database Entry, GenBank accession No. AF108959 (1998).
EMBL Database Entry, GenBank accession No. Am22543 (1998).
Fawell et al. “Tat-mediated delivery of heterologous proteins into cells” Proc. Natl. Acad. Sci. USA. 91(2), pp. 664-668 (1994).
GenBank Database Accession No. PH0878, May 1997.
Gotthardt et al. “Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction” J. Biol. Chem. 275(33), pp. 25616-25624 (2000).
Gura et al. “Systems for identifying new drugs are often faulty”, Science 278(5340): 1041-1042 (1997).
Heemskerk et al. “From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials”, Nat. Neurosci., 5:1027-1029 (2002).
Huq et al. “Specific recognition of HIV-1 TAR RNA by a D-Tat peptide”, Nat Struct Biol. 4(11), pp. 881-882 (1997).
Inhibit. Dictionary.com,. The American Heritage @ Stedman's Medical Dictionary. Houghton Mifflin Company. internet document <http://dictionary.reference.com.lbrowseinhibait>, accessed: Oct. 10, 2007, 1 page.
International Search Report for PCT/IB00/01538, dated Aug. 1, 2001.
International Search Report for PCT/IB0

Affiliated with

Also associated with

Rating

Cell-permeable peptide inhibitors of the JNK signal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell-permeable peptide inhibitors of the JNK signal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell-permeable peptide inhibitors of the JNK signal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4315159